Actively Recruiting

Age: 18Years - 70Years
All Genders
NCT04378023

Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.

Led by Hospital Vall d'Hebron · Updated on 2025-09-09

34

Participants Needed

1

Research Sites

370 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A prospective multicentre study which includes patients ≤ 70 years-old diagnosed of unresectable hilar cholangiocarcinoma (hCCA) ≤3cm in radial diameter, without evidence of lymph node or distant metastases. Liver transplantation preceded by neoadjuvant radio-chemotherapy will be performed in this selected group. The primary endpoint will be overall survival at 1, 3, and 5 years post-transplant. The secondary endpoints will be: 1) recurrence free survival at 1, 3 and 5 years post-transplant; 2) intention-to-treat survival of overall patients included in the study at 1,3 and 5 year; 3) the rate of patients included in the study who are finally transplanted.

CONDITIONS

Official Title

Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to provide written consent form
  • Age 70 years or younger
  • ECOG performance status of 0 or 1
  • Unresectable hilar cholangiocarcinoma measuring 3 cm or less in diameter
Not Eligible

You will not qualify if you...

  • Prior chemotherapy or radiotherapy outside this study protocol
  • Presence of liver, extrahepatic, or lymph node metastases
  • Previous attempt or intent of surgical resection or percutaneous biopsy
  • Previous or concurrent cancer different from adenocarcinoma at the primary site, except certain treated localized cancers
  • Uncontrolled infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of HPB Surgery and Transplants, Hospital Vall d´Hebron

Barcelona, Spain, 08035

Actively Recruiting

Loading map...

Research Team

C

CRISTINA DOPAZO, MD/PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here